Rankings
▼
Calendar
ORGO Q1 2023 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$355M
Q1 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$108M
+10.8% YoY
Gross Profit
$81M
75.3% margin
Operating Income
-$4M
-3.7% margin
Net Income
-$3M
-2.8% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
-6.8%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$446M
Total Liabilities
$182M
Stockholders' Equity
$264M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$108M
$97M
+10.8%
Gross Profit
$81M
$72M
+12.5%
Operating Income
-$4M
-$128,000
-3025.8%
Net Income
-$3M
-$913,000
-225.2%
Revenue Segments
Advanced Wound care
$101M
94%
Surgical and Sports Medicine
$7M
6%
← FY 2023
All Quarters
Q2 2023 →